Clinical Trials Directory

Trials / Completed

CompletedNCT03688412

Transvenous Lead Removal Post-Market Clinical Study

RELEASE: Transvenous Lead Removal Using the Cook Evolution® Lead Extraction System Post-Market Clinical Study.

Status
Completed
Phase
Study type
Observational
Enrollment
230 (actual)
Sponsor
Cook Research Incorporated · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This prospective, multicenter, post-market clinical study was designed to evaluate the outcomes of lead extraction of cardiovascular implantable electronic devices (CIED) using Cook catheter and lead extraction devices for any indication it is used in the commercial setting within the United States and Europe. The purpose of this clinical study is to collect data on the performance of the Cook lead extraction devices for the purpose of supporting publications and presentations

Conditions

Interventions

TypeNameDescription
DEVICECook lead extraction devicesThe Cook lead extraction devices are mechanical devices that encompass a full variety of devices required for percutaneous removal of CIED leads, indwelling catheters and foreign objects.

Timeline

Start date
2018-10-18
Primary completion
2020-01-28
Completion
2020-05-11
First posted
2018-09-28
Last updated
2020-05-28

Locations

9 sites across 4 countries: United States, Germany, Netherlands, United Kingdom

Source: ClinicalTrials.gov record NCT03688412. Inclusion in this directory is not an endorsement.

Transvenous Lead Removal Post-Market Clinical Study (NCT03688412) · Clinical Trials Directory